Myriad Genetics
MYGN
MYGN
219 hedge funds and large institutions have $568M invested in Myriad Genetics in 2025 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 84 increasing their positions, 75 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $640M → $568M (-$72.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
219
Holding in Top 10
–
Calls
$352K
Puts
–
Top Buyers
| 1 | +$14.2M | |
| 2 | +$7.18M | |
| 3 | +$4.52M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$3.38M |
| 5 |
BlackRock
New York
|
+$3.08M |
Top Sellers
| 1 | -$3.97M | |
| 2 | -$3.65M | |
| 3 | -$2.96M | |
| 4 |
HF
HRT Financial
New York
|
-$2.33M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$2.27M |
